Stockreport

Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds

Vaccinex, Inc.  (VCNX) 
PDF ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a di [Read more]